Medications

Pfizer agrees to let other companies make its COVID-19 pill

Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world's population.

Vaccination

'Strong' start to kids vaccine campaign, but challenges loom

The campaign to vaccinate elementary school age children in the U.S. is off to a strong start, health officials said Wednesday, but experts say there are signs that it will be difficult to sustain the initial momentum.

Vaccination

Pfizer asks FDA to OK COVID-19 booster shots for all adults

Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings.

Other

Pfizer lifts outlook as COVID-19 vaccine drives results

Pfizer again boosted its 2021 profit and revenue outlook on Tuesday, bolstered by the latest surge in COVID-19 vaccinations, including regulatory approvals for boosters and shots for younger children.

page 13 from 40